Alberto Palazzuoli
Alberto Palazzuoli is an expert in Cardiology at Azienda Ospedaliera Universitaria Senese (Italy). As of October 2026, ScienceLeadR ranks Alberto Palazzuoli in the top 1% of experts worldwide for Heart Failure. Alberto Palazzuoli has authored 346 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 4 of them ongoing. SLR score: 1,263 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Internal Medicine - Biochemistry - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2000 - 2026
Number : 346
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The complexity of congestion in heart failure: a critical review of the evidence and a proposal for a multimodality approach. PMID 42895733 — hospitalization, heart failure, heart, cardiovascular diseases, tissues | Eur Heart J Qual Care Clin Outcomes | 2026 | 0 |
| Dapagliflozin effects on right ventricular function, pulmonary pressure and coupling: a propensity score analysis from the RIVED-HF. PMID 42679352 — diabetes mellitus, heart failure, heart, propensity score, respect, drug-related side effects and adverse reactions, therapeutics, ventricular function, ventricular function, right | ESC Heart Fail | 2026 | 0 |
| Cardiac Resynchronization as an Enabler of ARNI Efficacy: Insights From a Real-World Cohort. PMID 42829576 — monitoring, ambulatory, hospitalization, heart failure, heart, cardiac resynchronization therapy, heart failure, systolic, therapeutics | J Arrhythm | 2026 | 0 |
| Precipitants of Acute Heart Failure: A State-of-the-art Review from an International Expert Group. PMID 42741576 — epidemiology, heart failure, heart, therapeutics | Card Fail Rev | 2026 | 0 |
| The Transition from Stage A to Stage B of Heart Failure: Risk Factors, Promoting Factors, and Opportunities for Prevention-An Update from the Italian Society of Cardiology Working Group on Heart Failure. PMID 42715030 — heart diseases, heart failure, heart, cardiovascular diseases, disease progression, cardiology, biomarkers, signs and symptoms, echocardiography, risk factors, diagnosis, natriuretic peptides | Eur J Prev Cardiol | 2026 | 0 |
Clinical Studies 11
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 5
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| HF POLARIS A research study to look at how well NNC0487 0111 works compared to placebo in people with heart failure and obesity 2025-523717-29-00 — mortality, safety, heart failure, heart, heart failure, diastolic, obesity, morbidity, research | Phase 3 | Recruiting | 2026 |
| HFpEF Phenotyping With Echo Clinical and Biomarkers NCT07642921 — diabetes mellitus, kidney diseases, heart failure, heart, heart failure, diastolic, kidney, biomarkers, obesity, renal insufficiency, renal insufficiency, chronic | N/A | Not yet recruiting | 2026 |
| Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution Identification of Cardiovascular Risk in Patients with Heart Failure NCT06884631 — exercise, heart failure, exercise test, heart, kidney, therapeutics, prognosis | N/A | Recruiting | 2021 |
| Right Ventricular Dysfunction in Chronic Heart Failure NCT06002321 — hypertension, laboratories, incidence, ventricular dysfunction, heart failure, heart, ventricular dysfunction, right, vena cava, inferior, signs and symptoms, pulmonary arterial hypertension, echocardiography, tricuspid valve insufficiency, atrial pressure | N/A | Not yet recruiting | 2023 |
LeadR Networks
Main global connection map